A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
Telerehabilitation in Oncology Patients
Phase NA Unknown
30 enrolled
RELEVENT
Phase 2 Unknown
60 enrolled
CHANCES
Phase 1 Unknown
27 enrolled
Safety/Tolerability, PK and Efficacy of IMB071703 Injection in Patients With Advanced Solid Tumors
Phase 1 Unknown
93 enrolled
DART
Phase 2 Unknown
124 enrolled
MINI-MD
Phase NA Unknown
30 enrolled
Imaging Guided Cementoplasty for Pelvic Bone Metastasis
Phase NA Unknown
20 enrolled
68Ga-PSMA PET in the Prostate Cancer
Phase NA Unknown
300 enrolled
68Ga-GPFAPI
Phase NA Unknown
30 enrolled
PET-MaN
Phase NA Unknown
150 enrolled
The Effect of Antenatal Education on Fear of Birth, Physiological Ability to Give Birth and Traumatic Birth Perception
Phase NA Unknown
42 enrolled
CELEBRATE
Phase 1/2 Unknown
78 enrolled
Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
Phase 2 Unknown
38 enrolled
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
Phase 1 Unknown
36 enrolled
Intratumoral CAN1012(Selective TLR7 Agonist) in Subjects With Solid Tumors
Phase 1 Unknown
36 enrolled
LoMP
Phase NA Unknown
80 enrolled
Clinical Study of SM3321 With Solid Tumors
Phase 1 Unknown
48 enrolled
CRLM-Z
Phase 1/2 Unknown
40 enrolled
Overcome, a Program of Therapeutic Exercise and Functional Recovery to Improve the Functional Capacity of Women With Breast Cancer and Bone Metastases
Phase NA Unknown
58 enrolled
ALPS
Unknown
3,000 enrolled
BIO-META
Unknown
10,000 enrolled
V-CHANCE
Phase 2 Unknown
39 enrolled
Study of BEBT-607 Tablets in The Treatment of Advanced or Metastatic Solid Tumors With KRAS G12C Mutation
Phase 1 Unknown
126 enrolled
CartDiagPROST
Unknown
90 enrolled
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
Phase 1/2 Unknown
172 enrolled
MSCs for the Treatment of Burn Wounds
Phase 1/2 Unknown
50 enrolled
TWICE-IRI
Phase 3 Unknown
202 enrolled
Minnelide 101
Phase 1 Unknown
66 enrolled
EPOST MBC
Phase NA Unknown
100 enrolled
Cognitive Outcome After SRS or WBRT in Patients With Multiple Brain Metastases (CAR-Study B)
Phase NA Unknown
81 enrolled
Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors
Unknown
100 enrolled
Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients
Unknown
20 enrolled
Comparison Between LDCT With DL Recontruction and Standard Dose CT
Unknown
134 enrolled
Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal Cancer
Phase 1 Unknown
24 enrolled
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Phase 1 Unknown
36 enrolled
A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T
Phase 1 Unknown
48 enrolled
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
Unknown
965 enrolled
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
Phase 3 Unknown
537 enrolled
HLX301
Phase 1/2 Unknown
30 enrolled
RAPASS
Unknown
10 enrolled
HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors
Phase 1 Unknown
148 enrolled
Fibroblast Activation Protein Inhibitor PET/CT Imaging in Malignant Tumor of Digestive System
Unknown
100 enrolled
GCTHCM
Unknown
354 enrolled
A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
126 enrolled
IRSTB030
Unknown
104 enrolled
The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment
Phase 2 Unknown
5 enrolled
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
Phase 2 Unknown
65 enrolled
A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors
Phase 1/2 Unknown
186 enrolled
A Study of TY-2136b in Patients With Advanced Solid Tumors Harboring ALK, ROS1 or NTRK1-3 Alterations
Phase 1 Unknown
282 enrolled